Integrated network pharmacology and experimental models uncover the mechanism of procyanidin B2 against ovarian carcinoma via EGFR/AKT pathway
{{output}}
Ovarian carcinoma (OC) remains a lethal malignancy with limited therapeutic options. Procyanidin B2, a natural flavonoid, has demonstrated broad bioactivity, yet its potential role in ovarian cancer remains incompletely understood. This study employed an integ... ...
